Abstract
Adore: A Randomized, Open-Label, Phase 1/2 Open-Platform Study Evaluating Safety and Efficacy of Novel Ruxolitinib Combinations in Patients with Myelofibrosis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have